1. Moderna heads to the FDA for an EUA for its COVID-19 vaccine — AstraZeneca plans extra trial for its COVID vaccine — Biogen bets $1.5B on Sage's failed depression drug — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Welcome to Aerigan

Discussion in 'Aerie Pharma' started by anonymous, Sep 3, 2020 at 7:30 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Mitro: Allergan
    Hockman: Allergan
    Parker: Allergan
    Hollander: Allergan
    Senchyna: Allergan
    Williams: Allergan

    They've take over!

  2. anonymous

    anonymous Guest

  3. anonymous

    anonymous Guest

    Who cares? Whoever post this is SAF
  4. anonymous

    anonymous Guest

    Yeah, shocking. With Aerie as an eyecare company, you would’ve thought they’d hire more executives WITHOUT Eyecare experience, RIGHT?!? I mean that makes sense. Who needs previous relationships with ophthalmologists when launching a start up company focusing on Eye health and new class of drugs.

    Fucking moron. Go back to your pod selling environment.
  5. anonymous

    anonymous Guest

    You are an idiot!